Sun Pharma

Company to launch once-weekly injectable for adults with type 2 diabetes in the South African market

Sun Pharma’s $12 billion acquisition of Organon will prove to be a milestone as the largest takeover by an Indian pharma company.…

While we agree that “what got us here (an affordable generics powerhouse) will not get us there (a leader in pharma innovation)”,…

Sun Pharma announced that it has received approval from the Drugs Controller General of India (DCGI) to manufacture and market a…

Sun Pharma announced UNLOXCYT (cosibelimab-ipdl) is now available in the US for healthcare professionals to  prescribe for adults…

As India moves into 2026, industry experts state that the next phase of growth in pharmaceuticals will depend on strengthening…

Programme records participation across premier management institutes and announces teams recognised in the grand finale

Sun Pharmaceutical announced the US Food and Drug Administration (FDA) approved an updated  label for UNLOXCYT (cosibelimab-ipdl)…

Sun Pharma announced the launch of its #SeeBeyondSugar campaign, a nationwide awareness and education initiative on Diabetic…

AstraZeneca Pharma India (‘AstraZeneca’), a leading science-led biopharmaceutical company and Sun Pharmaceutical Industries,…